SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that it has been awarded the 2007 Utah Innovation Award for Biotechnology/Pharmaceuticals. The award honors Q’s development of Q-Cells™, a cell therapy product used to regenerate the myelin sheath on neurons that have lost their insulating myelin layer due to disease or injury. The innovation has applicability to a wide variety of diseases and injuries of the central nervous system including multiple sclerosis, white matter stroke, spinal cord injury, and other demyelinating diseases of the human central nervous system. Q has exclusively licensed the technology underlying the Q-Cells from the University of Utah. The award was conferred by the Utah Technology Council in collaboration with Stoel Rives, LLC.
